Development of novel medicines using high resolution native mass spectrometry of intact protein assemblies
OMass is an Oxford University spin-out that is harnessing high-resolution native mass spectrometry and other biophysical technologies to drive drug discovery in high definition for immunology and genetic disease.
Date:
7 September 2021, 12:00 (Tuesday, 20th week, Trinity 2021)
Venue:
Zoom
Speaker:
Dr Katharina Duerr (OMass Therapeutics)
Organising department:
Divisional Office (MSD)
Organisers:
Sheena Lee (MSD Business Partnerships Office),
Medical Sciences Division Business Partnerships Office (University of Oxford)
Organiser contact email address:
sheena.lee@medsci.ox.ac.uk
Host:
Sheena Lee (MSD Business Partnerships Office)
Part of:
Industry Insight Seminar Series
Booking required?:
Required
Booking url:
https://www.eventbrite.co.uk/e/industry-insights-seminar-series-tickets-131313804123
Cost:
Free
Audience:
Members of the University of Oxford and the Biotech/Pharma industry
Editor:
Sheena Lee
